Introduction
============

Constrictive bronchiolitis obliterans (CBO) is a fibrotic lung disease primarily affecting the small (≤3 mm diameter) conducting airways of the lungs ([@b3-copd-2-593]). "Constrictive" bronchiolitis obliterans was first used as a descriptive term in 1973 ([@b7-copd-2-593]), and describes a fibrosing inflammatory process that surrounds, rather than fills, the airway lumen ([@b2-copd-2-593]). This process results in extrinsic airway compression and luminal obliteration. CBO is rare in adults, and has been poorly studied. In most cases, the etiologic agent associated with CBO is known, although the evidence underlying some of these associations is tenuous ([@b17-copd-2-593]). The term "cryptogenic obliterative bronchiolitis" was first used in 1981 to characterize cases of otherwise unexplained progressive airflow obstruction ([@b20-copd-2-593]). A small number of pathologically confirmed cryptogenic cases of CBO have however been documented ([@b10-copd-2-593]).

The bronchioles are a physiologically silent area of the lung as a result of their considerable cross-sectional area. The diameter of each successive distal airway generation decreases progressively from the tracheal division onward. However, the resulting total cross-sectional luminal area increases with each successive airway generation, a feature that attains the most significance in the conducting airways distal to the origin of the bronchioles ([@b1-copd-2-593]). Thus, extensive damage to the bronchioles may result in considerable pathophysiologic consequences. In CBO, where progressive obliteration of bronchioles leads to decreased conducting airway cross-sectional area, concomitant obstructive physiology develops that is complicated by air-trapping and hyperinflation.

Elastic fibers are composite structures containing two primary morphologically distinguishable components, elastin and microfibrils (reviewed in [@b9-copd-2-593]). Elastin, a major elastic fiber component, is known to be essential for lung development and mechanical function ([@b13-copd-2-593]), and elastic fibers are distributed throughout the lung, including the alveoli, airways, vessels and pleura. The rate of lung elastin synthesis is greatest during fetal and neonatal development, but is almost undetectable in healthy adult lung ([@b12-copd-2-593]). However, in pathological circumstances such as emphysema or pulmonary fibrosis, there may be reactivation of elastin expression in the adult lung leading to excessive or aberrant elastin deposition ([@b19-copd-2-593]; [@b11-copd-2-593]; [@b8-copd-2-593]). Functional fiber formation requires coordinated re-expression of all fiber components in a temporally and spatially regulated sequence. This is assumed to be an inefficient process in adult tissue, as re-initiated elastin deposition in injured adult tissues is often characterized by faulty organization of the newly formed three-dimensional fiber.

CBO predominantly affects small airways, with few or no histologic changes observed in the alveoli surrounding the diseased airways ([@b3-copd-2-593]). Given that CBO involves both airway injury and a fibrotic response, the finding of increased production of extracellular matrix components in the airways would not be surprising. While previous work has confirmed the presence of extensive collagenous fibrosis in the walls of bronchi with CBO ([@b14-copd-2-593]), elastin gene expression and protein deposition have been poorly characterized. Here, we report a case of cryptogenic bronchiolitis obliterans in which elastin expression and deposition are markedly and pathologically increased, not only in the affected bronchioles, but also in the surrounding alveoli.

Case report
===========

A 63-year-old man with a 5-month history of progressive dyspnea, cough, and scant sputum production was referred for pulmonary evaluation. Prior to the onset of dyspnea he was fully functional without exercise limitation. Onset of his symptomatology was coincident with the development of an upper respiratory infection. Outpatient therapy with antibiotics and bronchodilators had resulted in a minimal but temporary improvement. At presentation, the patient was dyspneic with showering and climbing any stairs. Social history was remarkable for a 5-year history of cigar smoking, which he discontinued 25-years prior to referral. Extensive questioning did not yield any significant history of occupational or environmental exposures, and family history was non-contributory for pulmonary disease. The patient had a history of a thymoma, but testing revealed no evidence of myasthenia gravis or any other systemic manifestations of thymic disease. CXR was significant for bilateral hyperinflation, without evidence of emphysema. CT scan again demonstrated marked hyperinflation with little evidence to suggest emphysema. Bilateral bronchiectasis and bronchiolitis with lower lobe predominance were evident. Extensive workup for causes of secondary bronchiectasis was unremarkable. Spirometry confirmed a partially reversible severe obstructive ventilatory defect, with an FEV~1~ = 0.67L (19% predicted) an FVC = 2.17L (48% predicted), and an FEV~1~: FVC ratio of 39%. Lung volumes revealed no hyperinflation with a TLC = 7.84L (109% predicted), but air trapping was significant with an RV = 5.28L (222% predicted). Resting ABG showed pH = 7.38, PaCO~2~ = 54, and PaO~2~ = 50 on room air, with a room-air SpO~2~ of 88%. Six-minute walk testing demonstrated that the patient required supplemental oxygen at 2 L/min at rest and 3 L/min with activity to maintain an SpO~2~ ≥90%. Despite aggressive therapy with oxygen, bronchodilators, intermittent antibiotics, anti-inflammatories (corticosteroids and macrolides), and rehabilitation, his disease continued to progress. Due to his severe clinical and physiologic impairments the patient was evaluated and listed for lung transplantation. Bilateral sequential lung transplantation was performed 3-months later without complication. At the time of surgery, the lungs were noted to be grossly hyperinflated, and did not deflate after resection and removal from the thorax. An explant wedge biopsy sent for pathologic examination revealed the diagnosis of constrictive bronchiolitis obliterans, which on the basis of his clinical history was considered cryptogenic in etiology. The rest of the lung was placed in storage at −80°C for further study. At the time of writing, the patient continues to do well \>15 months after transplantation.

Methods and materials
=====================

Lung processing
---------------

The explanted diseased lung was kept on ice during sampling, as was a donor lung rejected for transplantation that was used as a tissue control. Portions of peripheral lung 1 cm^2^ were excised with a scalpel and fixed without inflation in 4% paraformaldehyde overnight at 4 °C before paraffin embedding. Serial 5 μm-thick sections were cut, deparaffinized, and stained with hematoxylin and eosin (H and E). Identical sections were used for Hart's staining, in-situ hybridization and immunohistologic staining.

Hart's elastin staining
-----------------------

Peripheral CBO and control lung tissue sections (5 μm) embedded in paraffin were deparaffinized and re-hydrated through graded ethanol to PBS, then soaked in 0.25% potassium permanganate solution for 5 minutes. Slides were cleared in 5% oxalic acid and soaked in resorcin-fuchsin solution (Poly Scientific, Bay Shore, NY, USA) overnight. After washing in water, sections were counterstained with tartrazine (yellow), dehydrated through graded ethanol, cleared in xylene and mounted.

Smooth muscle actin immunohistochemistry
----------------------------------------

Sections of paraffin embedded peripheral CBO and control lung were deparaffinized in xylene, then re-hydrated in a descending ethanol series and allowed to stand in PBS for 10 minutes. Slides were blocked for 1 hour with 10% fetal horse serum, rinsed in PBS, then incubated overnight at 4 ºC with the primary alpha smooth muscle actin (α-SMA) antibody (1A4 mouse monoclonal, 1:200 dilution, Sigma, St. Louis, MO, USA). After rinsing in PBS, sections were incubated in the dark with secondary antibody (fluorescein-conjugated goat anti-mouse IgG, 1:250 dilution, 1 hour, room temperature, Jackson Immuno Research, Westgrove, PA). Following rinsing in PBS, sections were cover slipped using Vectashield mounting medium (Vector Laboratories, Burlingame, CA) and viewed under fluorescent light for image capture.

In situ hybridization
---------------------

Digoxygenin-labeled antisense and sense riboprobes were generated from a baboon tropoelastin cDNA that had been linearized for in vitro transcription (Promega, Madison, WI, USA). Sections of paraffin embedded peripheral CBO and control lung were deparaffinized, re-hydrated and digested with proteinase K. The tissue sections were blocked with triethanolamine and acetic anhydride, then hybridized with denatured digoxygenin-labeled riboprobe overnight at 60 °C. Following hybridizations, tissue sections were subjected to a series of washes including digestion with RNase A, treated with blocking agents, and incubated with an antibody conjugated to alkaline phosphatase. After additional washes, slides were incubated with a chromogen substrate for 1--3 days. After color development, specimens were counterstained with nuclear fast red.

Results
=======

Initial analysis of the CBO lung
--------------------------------

The explanted lung remained inflated after resection and was firm to the touch. When tissue specimens of approximately 1 cm^3^ were cut from the periphery of the lung, these too remained inflated. Gross examination showed no obvious emphysematous changes within peripheral tissue sections. Staining with hematoxylin and eosin (H and E) showed that the peripheral tissue had few bronchioles, but no evidence of emphysema, confirming the CXR, CT and formal pathologic findings. Inflammatory infiltrates were present adjacent to large airways paralleling intralobar arteries. Some particulate deposits were associated with the inflammatory infiltrates ([Figure 1](#f1-copd-2-593){ref-type="fig"}, arrowheads).

Excess elastic fiber deposition and mRNA expression
---------------------------------------------------

Because the lung exhibited unusual mechanical properties, did not deflate, and had no evidence of emphysematous changes, we next examined elastic fibers by staining with Hart's elastin stain ([Figure 1](#f1-copd-2-593){ref-type="fig"}, A′ and B′). Assessing and representing the integrity of elastic fibers in single sections is exceptionally difficult. Nonetheless, extensive analysis of a large number of sections revealed a high density of elastic fibers with a disorganized appearance, embedded within the tissue. Many of the elastic fibers displayed a fractured appearance (as represented in [Figure 1](#f1-copd-2-593){ref-type="fig"}, B′). To determine whether elastin synthesis was ongoing despite the accumulation of elastic fibers in the tissue, we performed in situ hybridization for elastin mRNA on serial sections of tissue ([Figure 1](#f1-copd-2-593){ref-type="fig"}, A″ and B″). This showed that elastin expression is active, and localizes to the walls of intralobar arteries, conducting airways, and terminal airways and alveoli adjacent to the inflammatory infiltrates. Within an inflammatory infiltrate encompassing a previously patent vessel, elastin expression localized to the vessel remnants ([Figure 1](#f1-copd-2-593){ref-type="fig"}, B′ and B″), identified on the basis of its elastic lamellae and α-smooth muscle actin (α-SMA) staining.

Increased smooth muscle and myofibroblasts in CBO
-------------------------------------------------

Elastic fibers in the lung are largely the product of smooth muscle cells of blood vessels and conducting airways and myofibroblasts within alveolar walls. Sections of CBO lung, along with normal and emphysematous control lungs, were stained for α-SMA to determine whether altered abundance or distribution of cells expressing a "myo" phenotype may be responsible for the abnormal elastin expression found in this adult lung specimen ([Figure 2](#f2-copd-2-593){ref-type="fig"}). The typical appearance and distribution of elastic fibers and alveolar myofibroblasts in normal adult human lung is shown in [Figure 2](#f2-copd-2-593){ref-type="fig"}, A and A′. Dense elastic fibers localize to alveolar tips, where small alveolar myofibroblasts expressing α-SMA reside. In emphysematous lung specimens, some areas exhibit a loss of elastic fibers associated with enlarged alveolar spaces, and the distribution of alveolar myofibroblasts is altered ([Figure 2](#f2-copd-2-593){ref-type="fig"}, B and B'). In the CBO lung, alveolar regions had dense, enlarged elastic fibers localizing to alveolar tips, where intensely staining myofibroblasts were found ([Figure 2](#f2-copd-2-593){ref-type="fig"}, C and C'). In multiple sections containing areas of extensive remodeling in the CBO specimens, dense accumulations of disorganized elastic fibers were populated by single cells and groups of cells staining intensely for α-SMA ([Figure 2](#f2-copd-2-593){ref-type="fig"}, D/E and D'/E').

Discussion
==========

In the case of cryptogenic CBO described, the root cause of the dyspnea and severe airways obstruction was suspected to be bronchiolitis, but the pathologic diagnosis was not confirmed until after lung transplantation. Upon explantation of the diseased lung, it was observed that the lung did not deflate, and that even sections of lung tissue removed for pathologic examination remained inflated. These unusual findings led to a more detailed analysis of the peripheral lung tissue, which was compared to other specimens from an ongoing study of elastic fiber changes in COPD. In marked contrast to emphysematous lungs, there was no evidence of alveolar septal destruction. In addition, alveolar elastic fibers were greatly increased in number and density compared to normal lung specimens.

The role of elastic fibers in CBO has not been well characterized. Pulmonary elastin is an extremely stable and long-lived polymer ([@b18-copd-2-593]), and the majority of lung elastin expression is limited to the alveolar stage of lung development ([@b15-copd-2-593]; [@b12-copd-2-593]). Thus, in normal uninjured adult lungs, elastin expression is virtually non-existent. Even in lung pathology associated with extensive remodeling, fibrosis due to excess collagen deposition is much more common than elastosis. Notably, the remodeling of airway walls in CBO is thought to be the result of unrestrained collagenous fibrosis ([@b14-copd-2-593]; [@b3-copd-2-593]; [@b21-copd-2-593]), a phenomenon that has been associated with and shown to be dependent upon increased transforming growth factor-beta (TGF-β) signaling ([@b16-copd-2-593]). A number of other genes have been shown to undergo upregulation in response to TGF-β signalling, including elastin ([@b5-copd-2-593]; [@b4-copd-2-593]) and alpha smooth muscle actin (α-SMA) ([@b6-copd-2-593]; [@b4-copd-2-593]). Most cell types expressing elastin in lung development, including airway and vascular smooth muscle cells and alveolar myofibroblasts, are positive for α-SMA, and upregulation of α-SMA has been implicated in the transition of cells to a myofibroblast phenotype in adults with idiopathic pulmonary fibrosis ([@b22-copd-2-593]). For these reasons, we examined this case to characterize elastin mRNA expression and the abundance of α SMA-positive cells.

The sampled lung showed evidence of severe CBO, with most of the areas demonstrating the phenomenon of 'disappearing' bronchioles, an indication of complete bronchiolar obliteration by the constrictive process. Elastic fibers were abundant, dense, thick, and ropy in appearance in the affected bronchioles, and in situ hybridization for elastin mRNA showed abundant elastin expression localized to the collapsed and diseased bronchiolar walls, which were the primary sites of excess elastin accumulation. In addition, a similar upregulation of elastin deposition was noted in the adjacent alveolar areas, and was more extensive than those observed in either normal or emphysematous lung specimens.

The combination of upregulated elastin gene expression along with myofibroblast (α-SMA-positive cell) proliferation, when compared with normal lung, leads us to hypothesize that the elastosis noted in the bronchiolar and alveolar walls is likely the result of recent elastin protein synthesis. The specific signals leading to increased myofibroblast abundance and elastin expression are still unknown in this case.
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![**Abnormal morphology, elastic fiber accumulation, and elastin mRNA expression in CBO**. Sections of peripheral lung tissue from CBO-affected lung (panels A and B), and control lung (panel C) were fixed without inflation, embedded, and sectioned at 5 μM. Serial sections were stained with H and E (**A, B, C**), for elastic fibers using Hart's elastic fiber stain (**A**′, **B**′, **C**′), and hybridized in situ for elastin mRNA (**A**″, **B**″, **C**″). In panel A, a large vessel (top of each panel) is flanked by a large airway (bottom left of each panel) with accumulation of particulates, visible as black deposits, between the vessel and airway (indicated by white arrow in **A** and **A**′). **A**′ shows elastic laminae (stained black) in the intralobar pulmonary artery, and an increased density of elastic fibers beneath the epithelium of the large airway and the surrounding lung parenchyma compared to control (**C**′). **A**″ shows that elastin mRNA expression (black signal) is present in the large blood vessel, conducting airway, and particularly in tissue between these structures, and is significantly increased compared to control lung (**C**″). Panel B shows a large infiltrate (top of panels) flanked by surrounding tissue containing obliterated airways. Elastin staining in **B**′ indicates the infiltrate likely encompasses an airway, as there is a continuous elastic fiber (outlined by white dashed line) indicating a luminal structure has been present. Again, elastin density is increased compared to control lung (**C**'). **B**″ shows ongoing, intense elastin mRNA expression in tissue surrounding the infiltrate that is greater than that seen in control lung (**C**″).](copd-2-593f1){#f1-copd-2-593}

![**Altered distribution and abundance of cells expressing α-SMA in CBO lung.** Serial sections of lung were stained with Hart's elastin stain (left panels) or for a-SMA (right panels). **A**: Alveolar section from a control lung specimen showing focal elastic fibers (black stained) at tips of alveolar walls (grey counterstain). **A**′: Serial section stained for a-SMA shows small alveolar myofibroblasts localizing to alveolar tips. **B**: Emphysematous lung specimen with diminished complexity, enlarged airspaces, and less elastin staining. **B**′ shows loss of focal staining for a-SMA. **C**: Alveolar region from CBO lung shows large focal elastic fibers at alveolar septal tips, and **C**′ shows enlarged myofibroblasts at the same sites staining intensely for a-SMA. **D** and **E:** Remodeled regions of CBO lung showing accumulation of thick elastic fibers. **D**′ and **E**′: The elastic fibers are surrounded by cells staining intensely for a-SMA.](copd-2-593f2){#f2-copd-2-593}
